Hematological malignancies represent defying clinical conditions affecting either the lymphoid or the myeloid lineages. Targeted therapy research is developing rapidly from bench to bedside based on ...

CAMBRIDGE, England, November 13, 2025--biomodal, an omics-based life sciences technology and analytics company, today announced it has filed a lawsuit against Watchmaker Genomics ("Watchmaker") in the ...

An emerging approach in AI innovation is hybrid AI, which combines the scalability of machine learning (ML) with the ...

Q3 Revenue of $8.8 million ●Q3 Cash Collections of $10.0 million ●Q3 Thyroid test volume up 12% year-over-year to record levels ●Q3 Thyroid revenue of $8.8M; up 22% year-over-year to record ...

While for many people AI translates to chatbots, thanks to the accessibility and popularity of generative AI tools like ...